Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Saharan Africa, despite reports of high levels of ART adherence in this setting. We sought to determine the relationship between very early ART adherence and early adverse outcomes in HIV-infected adults in Botswana.This prospective cohort study of 402 ART-naïve, HIV-infected adults initiating ART at a public HIV clinic in Gaborone, Botswana evaluated the relationship between suboptimal early ART adherence and HIV treatment outcomes in the initial months after ART initiation. Early adherence during the interval between initial ART dispensation and first ART refill was calculated using pill counts. In the primary analysis patients not returning t...
Two-thirds of the world's HIV-infected people live in sub-Saharan Africa, and more than 1.5 million ...
International audienceTwo-thirds of the world's HIV-infected people live in sub-Saharan Africa, and ...
International audienceTwo-thirds of the world's HIV-infected people live in sub-Saharan Africa, and ...
Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Sah...
Background Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common...
Background: Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are commo...
Background Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common...
OBJECTIVES: To describe associations between different summaries of adherence in the first year on a...
OBJECTIVES: To describe associations between different summaries of adherence in the first year on a...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
Background: Adherence to antiretroviral therapy (ART) is a strong predictor of progression to AIDS a...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
Development of HAART in the mid-1990’s and its continued scale up has revolutionized the treatment o...
BACKGROUND: Asymptomatic HIV-infected people who start ART early may feel less motivated and neglect...
Two-thirds of the world's HIV-infected people live in sub-Saharan Africa, and more than 1.5 million ...
International audienceTwo-thirds of the world's HIV-infected people live in sub-Saharan Africa, and ...
International audienceTwo-thirds of the world's HIV-infected people live in sub-Saharan Africa, and ...
Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Sah...
Background Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common...
Background: Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are commo...
Background Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common...
OBJECTIVES: To describe associations between different summaries of adherence in the first year on a...
OBJECTIVES: To describe associations between different summaries of adherence in the first year on a...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
Background: Adherence to antiretroviral therapy (ART) is a strong predictor of progression to AIDS a...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
Development of HAART in the mid-1990’s and its continued scale up has revolutionized the treatment o...
BACKGROUND: Asymptomatic HIV-infected people who start ART early may feel less motivated and neglect...
Two-thirds of the world's HIV-infected people live in sub-Saharan Africa, and more than 1.5 million ...
International audienceTwo-thirds of the world's HIV-infected people live in sub-Saharan Africa, and ...
International audienceTwo-thirds of the world's HIV-infected people live in sub-Saharan Africa, and ...